Search Results 2681-2690 of 19824 for CLL
-
Dr. Miller's laboratory is experienced in all types of pharmacological, biochemical, cell biological and biophysical approaches to the characterization of ...
-
Mortality and morbidity after combined heart and liver transplantation in the failing Fontan: An updated dual center retrospective study. Clin Transplant. 2024; ...
-
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
-
Leadership. The Community-Engaged Research Program is led by Mayo Clinic experts in health equity and community-engaged research.
-
Daniel H. Ahn, D.O., talks about the latest advancements and research in colorectal cancer treatment.
-
A Phase 1b/2, open label, multi-center, clinical study of Chimeric Antigen Receptor T Cells (CAR-T) targeting claudin18.2 in patients with advanced gastric, ...
-
M. Mayo Clinic Minute · Mayo Clinic Platform · Mayo Clinic Q&A · Mayo Clinic Q&A Podcast · Minnesota. N. News Releases. O. Orthopedics/Sports ...
-
The laboratory is using new knowledge derived from our research to develop innovative therapeutic approaches to restore antitumor immunity across a range of ...
-
In his Cholangiopathies Lab at Mayo Clinic, Nicholas F. LaRusso, M.D., studies cholangiocytes to discover better treatments for chronic, progressive liver ...
-
These benefactor-funded career development awards through Mayo Clinic's CCaTS support faculty members seeking to advance their translational research ...